Lanostane-type triterpenes from the sporoderm-broken spores of Ganoderma lucidum

Journal of Antibiotics

Volumn 65, Issue 3, 2012, Pages 165-167

  Ma, Bing Ji ^a   Zhou, Yan ^a   Ruan, Yuan ^a   Ma, Jin Chuan ^a   Ren, Wei ^a   Wen, Chun Nan ^a  

^a HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Ganoderma spores; lucialdehyde E; triterpene

Indexed keywords

GANODERIC ACID A; GANODERIC ACID C1; GANODERMANONDIOL; GANODERMANONTRIOL; GENODERIC ACID EPSILON; LUCIALDEHYDE D; LUCIALDEHYDE E; LUCIDUMOL A; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; GANODERMA LUCIDUM; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

GANODERMA; GANODERMA LUCIDUM;

EID: 84859131271     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2011.135     Document Type: Article

References (20)

1. Bojana, B., Marin, B., Zhang, J. S. & Lin, Z. B. Ganoderma lucidum and its pharmaceutically active compounds. Biotech. Ann. Rev. 13, 265-301 (2007).
2. Jong, S. C. & Birmingham, J. M. Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microb. 37, 101-134 (1992).
3. Lin, Z. B. & Wang, P. Y. The pharmacological study of Ganoderma spores and their active compounds. J. Peking Univ. (Health Sciences) 38, 541-547 (2006).
4. Zhang, W. & Zeng, Y. S. Progress on the spores of Ganoderma lucidum. J. Chin. Integr. Med. 2, 463-465 (2004).
5. Chen, R. Y. & Yu, D. Q. Progress on triterpenoids of Ganoderma lucidum. Acta Pharm. Sin. 25, 940-953 (1990).
6. Luo, J. & Lin, Z. B. Advances of pharmacological effects of triterpenes from Ganoderma lucidum. Acta Pharm. Sin. 37, 574-578 (2002).
7. 13C NMR chemical shifts of Ganoderma triterpenoids: a meta-analysis. Chin. J. Mag. Res. 22, 437-456 (2005).
8. Hou, C. Y., Sun, Y. T., Yan, L. & Xue, H. Studies on the chemical constituents of the spores from Ganoderma lucidum. Acta Bot. Sin. 30, 66-70 (1988).
9. Chen, R. Y. & Yu, D. Q. Application of 2D NMR techniques in the structure determination of ganosporelactone A and B. Acta Pharm. Sin. 26, 430-436 (1991).
10. Min, B. S., Nakamura, N., Miyashiro, H., Bar, K. W. & Hattori, M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. 46, 1607-1612 (1998).
11. Min, B. S., Gao, J. J., Nakamura, N. & Hattori, M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. 48, 1026-1033 (2000).
12. Min, B. S., Gao, J. J., Hattori, M., Lee, H. K. & Kim, H. Y. Anticomplement activity of triterpenoids from the spores of Ganoderma lucidum. Planta Med. 67, 811-814 (2001).
13. Zhu, H. S., Yang, X. L., Wang, L. B., Zhao, D. X. & Chen, L. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on Hela cells. Cell Biol. Toxicol. 16, 201-206 (2000).
14. Gao, J. J. et al. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem. Pharm. Bull. 50, 837-840 (2001).
15. Niedermeyer, T. H. J. et al. Antiviral terpenoid constituents of Ganoderma pfeifferi. J. Nat. Prod. 68, 1728-1731 (2005).
16. Morigiwa, A., Kitabatake, K., Fujimoto, Y. & Ikekawa, N. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem. Pharm. Bull. 34, 3025-3028 (1986).
17. Sliva, D., Sedlak, M. & Slivova, V. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J. Alter. Compl. Med. 9, 491-497 (2003).
18. Liu, Q. Y., Sartippour, M. R. & Brooks, M. N. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol. Rep. 12, 659-662 (2004).
19. Ma, L., Wu, F. & Chen, R. Y. Analysis of triterpene constituents from Ganoderma lucidum. Acta Pharm. Sin. 38, 50-52 (2003).
20. Ma, B. J. et al. Cytotoxic aromatic compounds from Hericium erinaceum. J. Antibiot. 63, 713-715 (2010).